Delivery Order SPE2DB22D3301-SPE2DB24FZ2UK
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,545.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a Delivery Order for the supply of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award, valued at $3,405.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, and has an ultimate completion date of December 21, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,369.46 firm-fixed-price delivery order is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of August 8, 2024 and was awarded on August 7, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen...
This federal contract award, with a ceiling value of $1,923.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract provides for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product, to support military treatment facilities and other federal healthcare providers. The contract has an ultimate completion date of September 26, 2024, and is a Firm Fixed Price Delivery Order. This award is not associated with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $1,627.41, is for the delivery of Fluticasone Propionate HFA 220 MCG 12GM, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is August 6, 2024. This award does not have a set-aside designation. Amerisourcebergen is a major supplier of...
This federal contract award, valued at $1,118.34, was issued by the Medical Supply Chain division of the Defense Agency to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products, with a completion date of July 2, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to...
This federal contract award, valued at $1,577.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a completion date of August 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award, valued at $1,175.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product, with a completion date of July 2, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $1,118.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567926196 - FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product. The award has an ultimate completion date of April 16, 2025 and is a Firm Fixed Price Delivery Order contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,398.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product, with a completion date of December 23, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation mentioned. Amerisourcebergen holds a significant Indefinite Delivery...